Enzalutamida en este contexto (CPRC): ¿cuáles son los pacientes? - page 4

Dynamic progression and patient flow model in prostate

cancer (1990-2009)

Scher et al. PLOS One 2015

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3 5,6,7,8,9,10,11,12,13,14,...42